Effect of thyroxine, testosterone, and corticosterone on nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mouse submaxillary gland: dissociation of NGF and EGF responses. 1981

P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher

Testosterone propionate (TP) and corticosterone acetate (CA) were administered alone and in combination with T4 to assess the effect on submaxillary gland (SMG) nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mice. Mice were treated for 5 or 10 days. SMG NGF, and EGF concentrations were measured by specific RIA techniques. Mean SMG NGF (0.68 +/- 0.08 microgram/mg protein) and EGF (0.58 +/- 0.05 microgram/mg protein) concentrations were similar in control mice. T4 (0.4 microgram/g BW, sc, daily) significantly increased mean SMG NGF and EGF concentrations to 469% and 347%, respectively, of control values after 5 days and to 1190% and 568%, respectively, after 10 days of treatment. TP (25 microgram/g BW, sc, every 2 days) significantly increased mean SMG NGF and EGF concentrations to 734% and 767%, respectively, of control values at 5 days and to 1971% and 1953%, respectively, at 10 days. T4 and TP resulted in no further significant increases in either SMG NGF or EGF concentrations above the levels observed after TP alone. CA (25 microgram/g BW, sc, daily) increased mean SMG NGF, but not EGF, concentrations at both 5 and 10 days. Moreover, T4 and CA appeared to exert an additive effect on NGF. In contrast to the observations in adult female mice, T4 increased mean SMG NGF concentrations to 178% of control levels in adult male mice, but had no significant effect of SMG EGF concentrations. These data indicate that T4 and TP modulate SMG NGF and EGF concentrations in adult female mice. T4, however, appears to have a preferential effect on NGF on both male and female mice, unlike the equal effect on TP on both NGF and EGF. CA, like T4, also appears to increase NGF, but not EGF, concentrations in adult female SMG. The present results suggest separate regulatory mechanisms for T4, TP, and CA on SMG NGF and EGF biosyntheses.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009414 Nerve Growth Factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. Neurite Outgrowth Factor,Neurite Outgrowth Factors,Neuronal Growth-Associated Protein,Neuronotrophic Factor,Neurotrophic Factor,Neurotrophic Factors,Neurotrophin,Neurotrophins,Growth-Associated Proteins, Neuronal,Neuronal Growth-Associated Proteins,Neuronotrophic Factors,Neurotrophic Protein,Neurotrophic Proteins,Proteins, Neuronal Growth-Associated,Factor, Neurite Outgrowth,Factor, Neuronotrophic,Factor, Neurotrophic,Factors, Nerve Growth,Factors, Neurite Outgrowth,Factors, Neuronotrophic,Factors, Neurotrophic,Growth Associated Proteins, Neuronal,Growth-Associated Protein, Neuronal,Neuronal Growth Associated Protein,Neuronal Growth Associated Proteins,Outgrowth Factor, Neurite,Outgrowth Factors, Neurite,Protein, Neuronal Growth-Associated
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013363 Submandibular Gland One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed) Submaxillary Gland,Gland, Submandibular,Gland, Submaxillary,Glands, Submandibular,Glands, Submaxillary,Submandibular Glands,Submaxillary Glands
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
October 1982, Endocrinology,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
June 1973, Biochemical pharmacology,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
January 1969, Brain research,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
May 2003, Neuroreport,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
December 1979, Endocrinology,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
January 1980, Experimental cell research,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
March 1986, Pediatric research,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
November 2014, Journal of molecular neuroscience : MN,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
November 1993, Nihon Sanka Fujinka Gakkai zasshi,
P Walker, and M E Weichsel, and S B Hoath, and R E Poland, and D A Fisher
October 1971, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!